BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC
All information is at 31 July 2013 and unaudited.
Performance at month end with net income reinvested
One Three One Since Three Five
month months year 1 April years years
2012
Sterling:
Share price 6.2% 5.7% 24.4% 28.9% 37.9% 31.4%
Net asset value 6.4% 4.4% 18.7% 19.0% 34.5% 21.2%
FTSE All-Share Total Return 6.8% 4.4% 24.3% 22.6% 43.4% 53.1%
Sources: BlackRock and Datastream
BlackRock took over the investment management of the Company with effect
from 1 April 2012.
At month end
Sterling:
Net asset value - capital only: 160.06p
Net asset value - cum income*: 162.36p
Share price: 161.00p
Total assets (including income): £47.0m
Discount to cum-income NAV: 0.8%
Gearing: 5.0%
Net yield**: 3.4%
Ordinary shares in issue***: 27,729,268
Gearing range (as a % of net assets) 0-20%
* includes net revenue of 2.30 pence per share
** based on final dividend of 3.45p per share in respect of the year ended 31
October 2012 and interim dividend of 2.00p per share in respect of the year
ending 31 October 2013.
*** excludes 5,204,664 shares held in treasury
Benchmark
Sector Analysis Total assets( %)
Oil & gas producers 13.7
Banks 12.1
Pharmaceuticals & biotechnology 9.9
Tobacco 9.4
Travel & leisure 5.6
Mobile telecommunications 5.2
Mining 4.9
Non-life insurance 4.6
Life insurance 4.5
Food producers 4.3
Support services 4.3
Financial services 4.2
Media 2.9
Gas, water & multiutilities 2.3
Electronic & electrical equipment 2.3
Real estate investment & services 2.3
General retailers 2.2
Fixed line telecommunications 1.9
Industrial engineering 1.6
Oil Equipment, services & distribution 1.2
Household goods & home construction 1.1
Non-Equity investment instruments 1.0
Net current liabilities (1.5)
------
Total 100.00
------
Ten Largest Equity Investments
Company % of Total assets
HSBC 7.4
Royal Dutch Shell B 7.3
British American Tobacco 6.2
GlaxoSmithKline 5.7
Vodafone 5.5
Imperial Tobacco 3.7
Shire 3.3
Rio Tinto 3.1
Legal & General 3.1
Reed Elsevier 3.1
Commenting on the markets, Adam Avigdori, representing the Investment Manager
noted:
Markets
The UK equity market rose in July, bouncing back by almost 7% after falling by 5%
in June, and nearly returning to the highs reached in May. Improving economic
data from around the world provided the boost to the market, along with some
positive comments through the current company reporting season. Financials, led
by banks and life insurers, were amongst the largest positive contributors to
market performance. Companies with more defensive earnings; oil producers,
tobacco, pharmaceuticals and food producers were the leading detractors as
macro data has improved.
Portfolio Performance
The portfolio returned +6.4% over the month, slightly behind the FTSE All-Share
Index return of +6.8%.
The main detractors to relative performance over the month included
defensive shares, reflecting a change in investor sentiment towards staples in
the last few weeks; holdings affected included Imperial Tobacco and Tate &
Lyle. The weak share price performance of Imperial Tobacco and British American
Tobacco demonstrated investor nervousness regarding their forthcoming results after
US competitor, Philip Morris International's earnings were lower than had been
anticipated and the firm downgraded full year earnings expectations. Carphone
Warehouse shares fell on the announcement that Best Buy's shareholding would be
placed in the market, although the shares began to recover following good
results mid-month. Domino's Pizza reported high costs in its German business
though we believe that the growth potential and investment case remain intact.
Shares of motor insurer eSure Group were affected by declining overall market
premium rates.
Pharmaceutical group Shire's second quarter earnings exceeded market expectations
delivering strong sales revenues and the company raised earnings guidance for the
full year. Reed Elsevier, the global professional information company, reported
interim results with underlying revenue, operating profit and earnings growth.
The underweight position in BP helped relative returns after the oil
producer reported disappointing quarterly earnings with lower net profit on
weaker downstream revenues and a higher tax charge. Cash flow was weak,
highlighting the challenge that the company faces in meeting its dividend
payments from operating cash flow.
During the month we initiated new positions in Stagecoach, Phoenix Group and
Howden Joinery; and added to BHP Billiton and BSkyB holdings. We sold the Rexam
position, and trimmed holdings in Unilever, Ladbrokes and Admiral Group.
Outlook
The UK equity market provides investors with exposure to international markets
and we believe that the earnings of UK companies can still grow despite the
challenges of low nominal GDP growth in the UK, due mainly to the greater part
of the revenues of larger UK companies being derived overseas. Equity
valuations have been lifted by a downward reassessment of risk levels in equity
investment, given higher levels of inflation and lower bond yields. UK equity
valuations still look attractive compared to those of most other asset classes,
with the prospect of high quality earnings and dividend growth.
Given the relative valuations we remain confident about equities in anticipation of
a modest level of top-line growth, influenced by improving trends in earnings
prospects on a global basis. We continue to focus on income, stock selection
and building a high conviction portfolio to deliver both income and capital
growth.
14 August 2013
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.